Historical record - last NADAC effective date: 11/18/2020
Product Information
NYSTATIN 100,000 UNIT/ML SUSP is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1426 per ML under NDC 51672411704. Its NADAC has been published 367 times since Nov 28, 2013.
FDA first approved this application on Feb 29, 1988.
Strength
100000 [USP'U]/mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672411704
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
11/18/2020
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA062876FDA Approved
2/29/1988
On Market Since
2/29/1988
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/ML SUSP has been published 367 times since Nov 28, 2013, and over the history we have for it it has declined 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1426 per ML |
|---|---|
| All-time high | $0.1822 (Feb 12, 2014) |
| All-time low | $0.1114 (Apr 17, 2019) |
| Median price | $0.1346 |
| Average price | $0.1409 |
| Largest weekly change | +20.7% (Aug 19, 2020) |
| Weeks tracked | 367 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-18.8%
Last surveyed Dec 2, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 59% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/ML SUSP, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1426 per ML (NDC 51672411704), effective Dec 2, 2020.
How has the price of NYSTATIN 100,000 UNIT/ML SUSP changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has declined 18.8%. It has been tracked across 367 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/ML SUSP?
Since Nov 28, 2013, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has ranged from a low of $0.1114 (Apr 17, 2019) to a high of $0.1822 (Feb 12, 2014), with a median of $0.1346 per ML.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/ML SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/ML SUSP, is $0.0584 per ML — about 59% below NYSTATIN 100,000 UNIT/ML SUSP.
Who manufactures NYSTATIN 100,000 UNIT/ML SUSP?
NYSTATIN 100,000 UNIT/ML SUSP (NDC 51672411704) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.